We can use our data to track individual stocks, industries, sectors, and indices. For today's bulletin, we present key metrics for the top picks in the NASDAQ 100. The companies listed below represent the top-ten STRONG BUY stocks within the index. They are presented below according to their one-month forecast target prices.
Gilead Sciences is the overall leader.
|
Ticker |
Company Name |
Market Price |
Valuation |
Last 12-M Retrn |
1-M Forecast Retn |
1-Yr Forecast Retn |
P/E Ratio |
Sector Name |
|
GILEAD SCIENCES |
105.85 |
-1.86% |
5.27% |
1.09% |
13.10% |
8.90 |
Medical |
|
|
AVAGO TECHNOLOG |
132.89 |
-2.95% |
46.11% |
1.03% |
12.43% |
16.14 |
Computer and Technology |
|
|
SKYWORKS SOLUTN |
83.76 |
-15.68% |
27.35% |
0.95% |
11.33% |
16.80 |
Computer and Technology |
|
|
AMER AIRLINES |
43.26 |
-7.91% |
-9.65% |
0.86% |
10.28% |
4.87 |
Transportation |
|
|
APPLE INC |
117.34 |
-6.46% |
1.97% |
0.79% |
9.43% |
12.57 |
Computer and Technology |
|
|
CISCO SYSTEMS |
27.57 |
0.32% |
-0.07% |
0.57% |
6.81% |
13.51 |
Computer and Technology |
|
|
MYLAN NV |
53.08 |
-17.00% |
-8.15% |
0.55% |
6.62% |
12.61 |
Medical |
|
|
LAM RESEARCH |
79.59 |
-0.28% |
-2.59% |
0.53% |
6.34% |
13.13 |
Computer and Technology |
|
|
EXPRESS SCRIPTS |
86.82 |
-0.47% |
3.79% |
0.51% |
6.14% |
15.82 |
Medical |
|
|
NXP SEMICONDUCT |
94.09 |
11.46% |
24.00% |
0.45% |
5.43% |
19.10 |
Computer and Technology |
Below is today's data on Gilead Sciences (GILD):
Gilead Sciences, Inc. is an independent biopharmaceutical company that seeks to provide accelerated solutions for patients and the people who care for them. They have a broad-based focus on developing and marketing drugs to treat patients with infectious diseases, including viral infections, fungal infections and bacterial infections, and a specialized focus on cancer. They have expertise in liposomal drug delivery technology, a technology that the company uses to develop drugs that are safer, easier for patients to tolerate and more effective.
VALUENGINE RECOMMENDATION: ValuEngine updated its recommendation from BUY to STRONG BUY for GILEAD SCIENCES on 2015-12-01. Based on the information we have gathered and our resulting research, we feel that GILEAD SCIENCES has the probability to OUTPERFORM average market performance for the next year. The company exhibits ATTRACTIVE Company Size and Sharpe Ratio.
|
ValuEngine Forecast |
||
|
Target |
Expected |
|
|---|---|---|
|
1-Month |
107.00 | 1.09% |
|
3-Month |
109.15 | 3.12% |
|
6-Month |
110.07 | 3.99% |
|
1-Year |
119.71 | 13.10% |
|
2-Year |
111.74 | 5.56% |
|
3-Year |
111.34 | 5.19% |
ValuEngine Market Overview
|
Summary of VE Stock Universe |
|
|
Stocks Undervalued |
50.29% |
|
Stocks Overvalued |
49.71% |
|
Stocks Undervalued by 20% |
22.81% |
|
Stocks Overvalued by 20% |
18.12% |
ValuEngine Sector Overview
|
Sector |
Change |
MTD |
YTD |
Valuation |
Last 12-MReturn |
P/E Ratio |
|
0.47% |
0.56% |
7.47% |
7.14% overvalued |
1.75% |
24.18 |
|
|
0.63% |
0.70% |
1.12% |
6.93% overvalued |
-1.26% |
25.03 |
|
|
0.06% |
0.13% |
-8.41% |
5.77% overvalued |
-8.16% |
17.65 |
|
|
0.80% |
0.97% |
6.07% |
5.24% overvalued |
6.73% |
28.46 |
|
|
0.30% |
0.39% |
4.39% |
4.98% overvalued |
2.10% |
29.30 |
|
|
0.43% |
0.46% |
3.48% |
3.38% overvalued |
-1.15% |
16.67 |
|
|
0.16% |
0.18% |
3.40% |
3.10% overvalued |
-1.45% |
20.53 |
|
|
0.53% |
0.64% |
3.93% |
2.61% overvalued |
-0.29% |
21.51 |
|
|
0.34% |
0.43% |
-4.98% |
0.32% undervalued |
-6.58% |
19.21 |
|
|
0.47% |
0.52% |
1.54% |
0.89% undervalued |
-2.63% |
25.49 |
|
|
0.38% |
0.44% |
-5.35% |
1.49% undervalued |
-7.38% |
22.52 |
|
|
0.10% |
0.25% |
-6.81% |
5.54% undervalued |
-6.10% |
23.03 |
|
|
-0.48% |
-0.39% |
-4.36% |
6.63% undervalued |
-6.95% |
13.77 |
|
|
-0.18% |
-0.02% |
-22.60% |
6.80% undervalued |
-35.65% |
24.04 |
|
|
0.42% |
0.46% |
-12.54% |
8.91% undervalued |
-17.81% |
14.47 |
|
|
0.83% |
0.92% |
-17.11% |
14.17% undervalued |
-22.89% |
23.30 |
ValuEngine.com is an independent research provider, producing buy/hold/sell recommendations, target price, and valuations on over 7,000 US and Canadian equities every trading day.
VALUATION WATCH: Overvalued stocks now make up 49.71% of our stocks assigned a valuation and 18.12% of those equities are calculated to be overvalued by 20% or more. Eight sectors are calculated to be overvalued.
Comments
Log in or sign up to join the conversation.